National institutes of health consensus development conference statement: Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 39, Issue 2, 2000, Pages 182-193

  Ferguson, John H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Attention deficit hyperactivity disorder; Barriers; Diagnosis; Psychostimulants; Risks; Treatment

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR MODIFICATION; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD BEHAVIOR; CHILD PSYCHIATRY; COGNITION; DRUG EFFICACY; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HUMAN; HYPERTENSION; LIVER INJURY; PRIORITY JOURNAL; PSYCHOTHERAPY; SEIZURE;

EID: 0033973866     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200002000-00018     Document Type: Article

References (108)

1. Overview and Introduction Conners CK, Erhardt D (1998), Attention-deficit hyperactivity disorder in children and adolescents. In: Comprehensive Clinical Psychology, Hersen M, Bellack A, eds. New York: Elsevier Science
2. Goldman LS, Genel M, Bezman RJ, Slanetz PJ (1998), Diagnosis and treatment of attention- deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 279:1100-1107
3. Richters JE, Arnold LE, Jensen PS et al. (1995), NIMM Collaborative Multisite Multimodal Treatment Study of Children With ADHD, I: background and rationale. J Am Acad Child Adolesc Psychiatry 34:987-1000
4. Weiss G, Hechtman L (1993), Hyperactive Children Grown Up: ADHD in Children, Adolescents, and Adults. New York: Guilford
5. ADHD as a Disorder in Children, Adolescents, and Adults Applegate B, Lahey BB, Hart EL et al.(1997), Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials, J Am Acad Child Adolesc Psychiatry 36:1211-1221
6. Carey WE, McDevitt SC (1995), Coping With Children's Temperament. New York: Basic Books
7. Castellanos FX, Giedd JN, March WL et al. (1996), Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:607-616
8. Diller LH (1998), Running on Ritalin. New York: Bantam
9. Lahey BB, Applegate B, McBurnett K et al. (1994), DSM-IV field trials for attention deficit/hyperactivity disorder in children and adolescents. Am J Psychiatry 151:1673-1685
10. Lahey BB, Carlson CL, Frick PJ (1997), Attention deficit disorder without hyperactivity: a review of research relevant to DSM-IV. In: DSM-IV Sourcebook, Vol 1, Widiger TA, Frances AJ, Davis W, First M, eds. Washington, DC: American Psychiatric Press
11. Lahey BB, Pelham WE, Stein MA et al. (1998), Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry 37:695-702
12. Levine MD (1998), Neurodevelopmental variation and dysfunction among school children. In: Developmental-Behavioral Pediatrics, 3rd ed, Levine MD, Carey WB, Crocker AC, eds. Philadelphia: Saunders
13. Lou HC (1996), Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxichaemodynamic encephalopathy. Acta Paediatr 85:1266-1271
14. Maziade M (1989), Should adverse temperament matter to the clinician? An empirically based answer. In: Temperament in Childhood, Kohnstamm GA, Bates JE, Rothbart MK, eds. New York: Wiley
15. Oosterlaan J, Logan GD, Sergeant JA (1998), Response inhibition in AD/HD, CD, comorbid AD/HD+CD, anxious and control children: a meta-analysis of studies with the stop task. J Child Pychol Pychiatry 39:411-426
16. Pennington BF, Ozonoff S (1996), Executive functions and developmental psychopathology. J Child Psychol Psychiatry 37:51-87
17. Seidman LJ, Biederman J, Faraone SV, Weber W, Ouellette C (1997), Toward defining a neuropsychology of attention deficit-hyperactivity disorder: performance of children and adolescents from a large clinically referred sample. J Consult Clin Psychol 65:150-160
18. Swanson JM, Sunohara GA, Kennedy JL et al. (1998), Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry 3:38-41
19. Tannock R (1998), Attention deficit hyperactivity disorder advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 39:65-99
20. Volkow ND, Ding YS, Fowler JS et al. (1995), Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatry 52:456-463
21. Impact Barkley RA (1998), Developmental course, adult outcome, and clinic-referred ADHD adults. In: Attention Deficit Hyperactivity Disorder, 2nd ed. New York: Guilford
22. Barkley RA, Fischer M, Edelbrock CS, Smallish L (1990), The adolescent outcome of hyperactive children diagnosed by research criteria, I: an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29:546-557
23. Biederman J, Faraone S, Milberger S et al. (1996), A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 53:437-446
24. Biederman J, Faraone SV, Spencer T et al. (1993), Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792-1798
25. Bird H (1996), Epidemiology of childhood disorders in a cross-cultural context. J Child Psychol Psychiatry 37:35-49
26. Bussing R, Zima BT, Belin TR, Forness SR (1998), Children who qualify for LD and SED programs: do they differ in level of ADHD symptoms and comorbid psychiatric conditions? J Emotional Behav Disord 22:88-97
27. Cocozza JJ, ed (1992), Responding to the Mental Health Needs of Youth in the Juvenile Justice System. Seattle: National Coalition for the Mentally Ill in the Criminal Justice System
28. Danckaerts M, Taylor EJ (1995), The epidemiology of childhood hyperactivity. In: The Epidemiology of Child and Adolescent Psychopathology, Verhulst FC, Koot HM, eds. New York: Oxford University Press
29. DuPaul GJ, Eckert TL (1997), The effects of school-based interventions for attention deficit hyperactivity disorder: a meta analysis. Sch Psychol Rev 26:5-27
30. Forness SR, Walker HM (1994), Special Education and Children With ADD/ADHD. Mentor, OH: National Attention Deficit Disorder Association
31. Greene R, Biederman J, Faraone SV, Sienna M, Garcia-Jetton J (1997), Adolescent outcome of boys with attention-deficit/hyperactivity disorder and social disability: results from a 4-year follow-up study. J Consult Clin Psychol 65:758-767
32. Hinshaw SP, Melnick SM (1995), Peer relationships in children with attention-deficit hyperactivity disorder with and without comorbid aggression. Dev Psychopathol 7:627-647
33. Lahey BB, Pelham WE, Stein MA et al. (1998), Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Acad Child Adolesc Psychiatry 37:435-442
34. Leung PW, Luk SL, Ho TP, Taylor E, Mak FL, Bacon-Shone J (1996), The diagnosis and prevalence of hyperactivity in Chinese schoolboys. Br J Psychiatry 168:486-496
35. Loeber R, Farrington D, eds (1998), Serious and Violent Juvenile Offenders: Risk Factors and Successful Interventions. Thousand Oaks, CA: Sage
36. Mann EM, Ikeda Y, Mueller CW et al. (1992), Cross-cultural differences in rating hyperactive-disruptive behaviors in children. Am J Psychiatry 149:1539-1542
37. Mannuzza S, Klein R, Bessler A, Malloy P, LaPadula M (1993), Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565-576
38. Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME (1997), Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry 36:1222-1227
39. Reid R, Maag JW, Vasa SE Wright G (1994), Who are the children with attention deficit-hyperactivity disorder? A school-based survey. J Spec Educ 28:117-137
40. Slomkowski C, Klein RG, Mannuzza S (1995), Is self-esteem an important outcome in hyperactive children? J Abnorm Child Psychol 23:303-315
41. Snyder HN (1997), Juvenile Arrests 1996. Washington, DC: US Department of Justice, Office of Juvenile Justice and Delinquency Prevention
42. Stahl AL (1998), Delinquency Cases in Juvenile Courts, 1995 (OJJDP Fact Sheet 79). Washington, DC: US Department of Justice, Office of Juvenile Justice and Delinquency Prevention
43. Weiss G, Hechtman LT (1993), Hyperactive Children Grown Up, 2nd ed. New York: Guilford
44. Safety and Efficacy of Treatments - Short- and Long-Term Arnold L, Abikoff H, Cantwell D et al. (1997), NIMH Collaborative Multimodal Treatment Study of Children With ADHD (MTA): design challenges and choices. Arch Gen Psychiatry 54:865-870
45. Biederman J, Baldessarini RJ, Wright V, Keenan K, Faraone S (1993), A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder, III: lack of impact of comorbidity and family history on clinical response. J Am Acad Child Adolesc Psychiatry 32:199-204
46. Biederman J, Trusted R, Greenhill L, Ryan N (1995), Estimation of the association between desipramine and the risk for sudden death in 5 to 14 year old children. J Clin Psychiatry 56:87-93
47. Borcherding BG, Keysor CS, Rapoport JL, Elia J, Amass J (1990), Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability? Psychiatry Res 33:83-94
48. Breggin PR (1998), Talking Back to Ritalin. Monroe, ME: Common Courage Press
49. Carbon CL, Pelham WE, Milich R, Dixon J (1992), Single and combined effects of mediylphenidate and behavior therapy on the classroom performance of children with ADHD. J Abnorm Child Psychol 20:213-232
50. Dunnick JK, Hailey JR (1995), Experimental studies on the long-term effects of methylphenidate hydrochloride. Toxicology 103:77-84
51. Goldman LS, Genel M, Bezman RJ, Slanetz PJ (1998), Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs. American Medical Association. JAMA 279:1100-1107
52. Hechtman L, Abikoff H (1995), Multimodal treatment plus stimulants vs. stimulant treatment in ADHD children: results from a two year comparative treatment study. Paper presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Orleans, October
53. Hinshaw SP (1991), Stimulant medication and the treatment of aggression in children with attentional deficits. J Child Psychol 20:301-312
54. Horn WF, Ialongo NS, Pascoe JM et al. (1991), Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children. J Am Acad Child Adolesc Psychiatry 30:233-240
55. Jensen PS, Abikoff H (in press),Tailoring treatment interventions for individuals with ADDs. In: Attention Deficit Disorders and Comorbidities in Children, Adolescents, and Adults, Brown T, ed. Washington, DC: American Psychiatric Press
56. Klein RG, Abikoff H (1997), Behavior therapy and methylphenidate in the treatment of children with ADHD. J Attention Disord 2:89-114
57. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S (1997), Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 54:1073-1080
58. Klein RG, Landa B, Mattes JA et al. (1998), Methylphenidate and growth in hyperactive children. Arch Gen Psychiatry 45:1127-1130
59. Marotta PJ, Roberts EA (1998), Pemoline hepatotoxicity in children. J Pediatr 132:894-897
60. McMaster University Evidence-Based Practice Center (1998), The Treatment of Attention-Deficit/Hyperactivity Disorder: An Evidence Report (Contract 290-97-0017). Rockville, MD: Agency for Health Care Policy and Research
61. Melega WP, Raleigh MJ, Stout DB, Lacan G, Huang SC, Phelps ME (1997), Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res 766:113-120
62. Nasrallah H, Loney J, Olson S, McCalley-Whiners M, Kramer J, Jacoby C (1986), Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry Res 17:241-246
63. Pelham WE, Hoza B (1996), Intensive treatment: a summer treatment program for children with ADHD. In: Psychosocial Treatments for Child and Adolescent Disorders: Empirically Based Strategies for Clinical Practice, Hibbs E, Jensen P, eds. New York: APA Press, pp 311-340
64. Pelham WE, Murphy HA (1986), Attention deficit and conduct disorder. In: Pharmacological and Behavioral Treatment: An Integrative Approach, Hersen M, ed. New York: Wiley, pp 108-148
65. Pelham WE, Wheeler T, Chronis A (1998), Empirically supported psychosocial treatments for attention deficit hyperactivity disorder J Clin Child Psychol 27:189-204
66. Pliszka S (1989), Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry 28:882-887
67. Safer D, Zito J, Fine E (1996), Increased methylphenidate usage for attention deficit hyperactivity disorder in the 1990s. Pediatrics 98:1084-1088
68. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S (1996), Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 35:409-432
69. Swanson JM, Flockhart D, Udrea D, Cantwell DP, Connor DF, Williams L (1995), Clonidine in the treatment of ADHD: questions about safety and efficacy. J Child Adolesc Psychopharmacol 5:301-304
70. Wilens TE, Biederman J (1992), The stimulants. Psychiatr Clin North Am 15:191-222
71. Substance Abuse Risks of Stimulant Treatments Beck L, Langford W, MacKay M, Sum G (1975), Childhood chemotherapy and later drug abuse and growth curve: a follow-up study of 30 adolescents. Am J Psychiatry 132:436-438
72. Biederman J, Wilens TE, Mick E, Milberger S, Spencer TJ, Faraone SV (1995), Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152:1652-1658
73. Carroll KM, Rounsaville BJ (1993), History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 34:75-82
74. Drug Enforcement Administration, Office of Diversion Control (1995), Methylphenidate Review: Eight Factor Analysis. Washington, DC: Drug Enforcement Administration
75. Drug Enforcement Administration, Office of Diversion Control (1996), Conference Report: Stimulant Use in the Treatment of ADHD. Washington, DC: Drug Enforcement Administration
76. Gaytan O, al-Rahim S, Swann A, Dafny N (1997), Sensitization to locomotor effects of methylphenidate in the rat. Life Sci 61:101-107
77. Hartsough CS, Lambert NM (1987), Pattern and progression of drug use among hyperactives and controls: a prospective short-term longitudinal study. J Child Psychol Psychiatry 28:543-553
78. Hechtman L (1985), Adolescent outcome of hyperactive children treated with stimulants in childhood: a review. Psychopharmacol Bull 21:178-191
79. Herrero ME, Hechtman L, Weiss G (1994), Antisocial disorders in hyperactive subjects from childhood to adulthood: predictive factors and characterization of subgroups. Am J Orthopsychiatry 64:510-521
80. Jaffe SL (1991), Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiatry 30:773-775
81. Klein RG, Mannuzza S (in press), The importance of childhood hyperactivity in the development of substance use disorders. In: Addictions et Psychiatrie, Bailly D, ed. Paris: Editions Masson
82. Kramer J, Loney J (1982), Childhood hyperactivity and substance abuse: a review of the literature. In: Advances in Learning and Behavioral Disabilities, Gadow KD, Bialer I, eds. Greenwich, CT: Jai Press
83. Lambert NM (1988), Adolescent outcomes for hyperactive children: perspectives on general and specific patterns of childhood risk for adolescent educational, social, and mental health problems. Am Psychol 43:786-799
84. Lambert NM, Hartsough CS (1998), Prospective study of tobacco smoking and substance dependence among samples of ADHD and non-ADHD subjects. J Learn Disabil 31:533-544
85. Lambert NM, Hartsough CS, Sandoval J (1990), Children's Attention and Adjustment Survey: Home and School Versions. Circle Pines, MN: American Guidance Service
86. Lambert NM, Sandoval J, Sassone D (1978), Prevalence of hyperactivity in elementary school children as a function of social system definers. Am J Orthopsychiatry 48:446-463
87. Levin FR, Kleber HD (1995), Attention deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv Rev Psychiatry 2:246-258
88. Loney J, Kramer J, Salisbury H (1998), Medicated vs. Unmedicated Hyperactive Boys as Adults: Attitudes Toward and Use of Substances. Stony Brook, NY: State University of New York
89. Lynskey MT, Fergusson DM (1995), Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use. J Abnorm Child Psychol 23:281-302
90. McDougall SA, Duke MA, Bolanos CA, Crawford CA (1994), Ontogeny of behavioral sensitization in die rat: effects of direct and indirect dopamine agonists. Psychopharmacology 116:483-490
91. Milberger S, Biederman J, Faraone S, Chen L, Jones J (1997), ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 36:37-44
92. Piazza PV, Deroche V, Rouge-Pont F, LeMoal M (1998), Behavioral and biological factors associated with individual vulnerability to psychostimulant abuse. In: Laboratory Behavioral Studies of Vulnerability to Drug Abuse (NIDA monograph 169, NIH Publication 98-4122), Wetherington CL, Falk JL, eds. Rockville, MD: NIH
93. Pierce RC, Kalivas PW (1997), A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216
94. Post RM (1980), Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci 26:1275-1282
95. Rappley MD (1995), The descriptive epidemiology of methylphenidate in Michigan. Arch Pediatr Adolesc Med 149:675-679
96. Report of the International Narcotics Control Board for 1996 (E/INCB/1996/1)
97. Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T (1997), Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 185:475-482
98. Existing Practices and Barriers Regarding Assessment and Treatment Costello EJ, Edelbrock C, Costello AJ, Dulcan MK, Barne BJ, Brent D (1988), Psychopathology in pediatric primary care: the new hidden morbidity. Pediatrics 81:415-424
99. Diller LH (1996),The run on Ritalin: attention deficit disorder and stimulant treatment in the 1990s. Hastings Cent Rep 26:12-18
100. Horwitz SM, Leaf PJ, Leventhal JM, Forsyth B, Speechley KN (1992), Identification and management of psychosocial and developmental problems in community-based primary care pediatric practices. Pediatrics 89:480-485
101. Jensen PS, Kettle L, Roper MT et al. Are stimulants overprescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry 38:797-804
102. Kelleher KJ, Childs GE, Wasserman RC, McInerny TK, Nutting PA, Gardner WP (1997), Insurance status and recognition of psychosocial problems: a report from pediatric research in office settings and the ambulatory sentinel practice networks. Arch Pediatr Adolesc Med 151:1109-1115
103. Knapp M (1997), Economic evaluations and interventions for children and adolescents with mental health problems. J Child Psychol Psychiatry 38:3-25
104. Leaf PJ, Alegria M, Cohen P et al. (1996), Mental health service use in the community and schools: results from the four-community MECA study. J Am Acad Child Adolesc Psychiatry 35:889-897
105. Offord DR, Boyle MH, Szatmari P et al. (1987), Ontario Child Health Study, II: six-month prevalence of disorder and rates of service utilization. Arch Gen Psychiatry 44:832-836
106. Rappley MD, Gardiner JC, Jetton JR, Houang RT (1995),The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med 149:675-679
107. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J (1996), Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 35:319-324
108. Wolraich ML, Lindgren S, Stromquist A, Milich R, Davis C, Watson D (1990), Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 86:95-101